JP2023511524A5 - - Google Patents
Info
- Publication number
- JP2023511524A5 JP2023511524A5 JP2022540698A JP2022540698A JP2023511524A5 JP 2023511524 A5 JP2023511524 A5 JP 2023511524A5 JP 2022540698 A JP2022540698 A JP 2022540698A JP 2022540698 A JP2022540698 A JP 2022540698A JP 2023511524 A5 JP2023511524 A5 JP 2023511524A5
- Authority
- JP
- Japan
- Prior art keywords
- lacto
- lnfp
- fucopentaose
- nucleic acid
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA202000088 | 2020-01-23 | ||
| DKPA202000088 | 2020-01-23 | ||
| PCT/EP2021/051466 WO2021148610A1 (en) | 2020-01-23 | 2021-01-22 | Hmo production |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023511524A JP2023511524A (ja) | 2023-03-20 |
| JP2023511524A5 true JP2023511524A5 (https=) | 2023-09-22 |
Family
ID=74505190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022540698A Pending JP2023511524A (ja) | 2020-01-23 | 2021-01-22 | Ｈｍｏ産生 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230109661A1 (https=) |
| EP (1) | EP4093748A1 (https=) |
| JP (1) | JP2023511524A (https=) |
| CN (1) | CN114981291B (https=) |
| BR (1) | BR112022014420A2 (https=) |
| WO (1) | WO2021148610A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK181497B1 (en) * | 2021-05-17 | 2024-03-12 | Dsm Ip Assets Bv | ENHANCING FORMATION OF THE HMOS LNT AND/OR LNnT BY MODIFYING LACTOSE IMPORT IN THE CELL |
| DK181991B1 (en) | 2021-11-11 | 2025-05-15 | Dsm Ip Assets Bv | Combined fermentation process for producing one or more human milk oligosaccharide(s) (hmo(s)) in escherichia coli |
| DK181683B1 (en) | 2022-03-02 | 2024-09-20 | Dsm Ip Assets Bv | Cells exprssing new sialyltransferases for in vivo synthesis of lst-a, methods using same and constructs encoding said sialyltransferases |
| DK181319B1 (en) | 2022-03-02 | 2023-08-10 | Dsm Ip Assets Bv | Genetically engineered cells and methods comprising use of a sialyltransferase for in vivo synthesis of 3’sl |
| CN118786221A (zh) | 2022-03-02 | 2024-10-15 | 帝斯曼知识产权资产管理有限公司 | 用于体内合成3'sl和6'sl的新型唾液酸转移酶 |
| EP4514989A1 (en) | 2022-04-29 | 2025-03-05 | DSM IP Assets B.V. | Hmo producing microorganism with increased robustness towards glucose gradients |
| EP4577061A1 (en) | 2022-08-25 | 2025-07-02 | DSM IP Assets B.V. | Hybrid method for producing complex hmos |
| CN120265786A (zh) | 2022-11-25 | 2025-07-04 | 帝斯曼知识产权资产管理有限公司 | 用于生产寡糖的双菌株系统 |
| CN120677242A (zh) | 2023-02-24 | 2025-09-19 | 帝斯曼知识产权资产管理有限公司 | 用于体内合成人乳寡糖的产物特异性转运蛋白 |
| DK181822B1 (en) | 2023-06-07 | 2025-01-30 | Dsm Ip Assets Bv | Genetically engineered strains with reduced byproduct formation and methods and uses of same |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2440661T3 (en) | 2009-06-08 | 2018-03-12 | Jennewein Biotechnologie Gmbh | HMO synthesis |
| DE12746649T1 (de) | 2011-02-16 | 2016-09-29 | Glycosyn LLC | Biosynthese menschlicher milcholigosaccaride in manipulierten Bakterien |
| PL2927316T3 (pl) * | 2014-03-31 | 2019-05-31 | Jennewein Biotechnologie Gmbh | Całkowita fermentacja oligosacharydów |
| WO2015188834A1 (en) | 2014-06-11 | 2015-12-17 | Glycom A/S | Separation of 2'-o-fucosyllactose from fermentation broth |
| AU2015315110B2 (en) | 2014-09-09 | 2021-04-08 | Glycosyn LLC | Alpha (1,3) fucosyltransferases for use in the production of fucosylated oligosaccharides |
| DK3233875T3 (en) | 2014-12-16 | 2022-12-19 | Glycom As | Separation of 2'-fl from a fermentation broth |
| EP3141610A1 (en) | 2015-09-12 | 2017-03-15 | Jennewein Biotechnologie GmbH | Production of human milk oligosaccharides in microbial hosts with engineered import / export |
| ES2991621T3 (es) | 2016-03-07 | 2024-12-04 | Glycom As | Separación de oligosacáridos de caldo de fermentación |
| DK3445770T3 (da) | 2016-04-19 | 2026-02-23 | Glycom As | Separering af oligosaccharider fra fermenteringssuppe |
| ES2856749T3 (es) | 2016-10-29 | 2021-09-28 | Chr Hansen Hmo Gmbh | Proceso para la producción de oligosacáridos fucosilados |
| CN111727253B (zh) * | 2017-12-21 | 2024-08-27 | 格礼卡姆股份公司 | 用于体外和体内基因表达的核酸构建体 |
| US20190323052A1 (en) | 2018-04-23 | 2019-10-24 | Dupont Nutrition Biosciences Aps | Increasing export of 2? fucosyllactose from microbial cells through the expression of a heterologous nucleic acid |
| US20190323053A1 (en) | 2018-04-23 | 2019-10-24 | Dupont Nutrition Biosciences Aps | Increasing activity of 2? fucosyllactose transporters endogenous to microbial cells |
| EP3569713A1 (en) * | 2018-05-16 | 2019-11-20 | Jennewein Biotechnologie GmbH | Use of glycosidases in the production of oligosaccharides |
| US10519475B1 (en) | 2018-11-21 | 2019-12-31 | Amyris, Inc. | Biosynthesis of compounds in yeast |
-
2021
- 2021-01-22 US US17/759,275 patent/US20230109661A1/en active Pending
- 2021-01-22 BR BR112022014420A patent/BR112022014420A2/pt not_active Application Discontinuation
- 2021-01-22 WO PCT/EP2021/051466 patent/WO2021148610A1/en not_active Ceased
- 2021-01-22 EP EP21702884.4A patent/EP4093748A1/en active Pending
- 2021-01-22 CN CN202180010202.2A patent/CN114981291B/zh active Active
- 2021-01-22 JP JP2022540698A patent/JP2023511524A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023511524A5 (https=) | ||
| JP2023511527A5 (https=) | ||
| JP2023511523A5 (https=) | ||
| JP2023511522A5 (https=) | ||
| CN115003687B (zh) | Hmo生产 | |
| CN114981291B (zh) | Hmo产生 | |
| CN115003814A (zh) | Hmo产生 | |
| CN114981290A (zh) | Hmo生产 | |
| DK180952B1 (en) | A dfl-producing strain | |
| WO2021082352A1 (zh) | 一种合成乳-n-二糖的方法 | |
| Davis et al. | Cloning and sequence of a chicken α-N-acetylgalactosaminidase gene | |
| US20230109937A1 (en) | New major facilitator superfamily (mfs) protein (fred) in hmo production | |
| US20200061210A1 (en) | Novel method for gene therapy using intranasal administration of genetically modified viral vectors | |
| JP2025530172A (ja) | Ｌ－フコース代謝が可能な組換えサッカロミセス・ボウラディ | |
| EA046005B1 (ru) | НОВЫЙ БЕЛОК СУПЕРСЕМЕЙСТВА ОСНОВНЫХ ПЕРЕНОСЧИКОВ (MFS) (Fred) В ПРОИЗВОДСТВЕ ОГМ | |
| CA3229155A1 (en) | Therapeutic engineered microbial cell systems and methods for treating conditions in which oxalate is detrimental | |
| EA046260B1 (ru) | Получение огм | |
| CN117821459A (zh) | Klrb1基因完全敲除的抗多杀性巴氏杆菌猪模型的构建方法 | |
| CN118530922A (zh) | 靶向工程菌及其构建方法和应用以及治疗结肠炎的药物 | |
| CN120988074A (zh) | 重组rsv f蛋白、rna分子及其医药用途 |